Total Payments
$15,904
2024 Payments
$2,377
Companies
54
Transactions
986
Medicare Patients
2,503
Medicare Billing
$314,209
Payment Breakdown by Category
Food & Beverage$15,426 (97.0%)
Other$260.09 (1.6%)
Education$217.62 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,426 | 961 | 97.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $260.09 | 18 | 1.6% |
| Education | $217.62 | 7 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $1,593 | 88 | $0 (2024) |
| Biogen, Inc. | $1,522 | 103 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $1,482 | 111 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,204 | 83 | $0 (2024) |
| ABBVIE INC. | $822.57 | 39 | $0 (2024) |
| Amgen Inc. | $789.82 | 45 | $0 (2022) |
| Teva Pharmaceuticals USA, Inc. | $569.82 | 35 | $0 (2023) |
| GENZYME CORPORATION | $546.57 | 29 | $0 (2023) |
| ACADIA Pharmaceuticals Inc | $526.42 | 31 | $0 (2024) |
| Genentech USA, Inc. | $512.26 | 49 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,377 | 119 | UCB, Inc. ($502.04) |
| 2023 | $2,163 | 110 | AbbVie Inc. ($351.49) |
| 2022 | $1,712 | 94 | Biogen, Inc. ($184.59) |
| 2021 | $2,034 | 134 | Novartis Pharmaceuticals Corporation ($291.01) |
| 2020 | $1,397 | 93 | Biogen, Inc. ($221.44) |
| 2019 | $2,582 | 178 | Sunovion Pharmaceuticals Inc. ($730.68) |
| 2018 | $2,007 | 152 | Sunovion Pharmaceuticals Inc. ($414.36) |
| 2017 | $1,630 | 106 | Biogen, Inc. ($183.14) |
All Payment Transactions
986 individual payment records from CMS Open Payments — Page 1 of 40
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Axonics, Inc. | Bulkamid (Device) | Food and Beverage | In-kind items and services | $22.28 | General |
| Category: Urology | ||||||
| 12/18/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $28.60 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Neurology | ||||||
| 12/11/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: Neurology | ||||||
| 12/05/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $25.05 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 12/05/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.15 | General |
| 12/03/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Neurology | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $3.09 | General |
| Category: PAIN | ||||||
| 11/21/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Neuroscience | ||||||
| 11/21/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: PAIN | ||||||
| 11/19/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/14/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: Neurology | ||||||
| 11/14/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Neurology | ||||||
| 11/13/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: PAIN | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Neurology | ||||||
| 10/31/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: NEUROLOGY | ||||||
| 10/31/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $2.21 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $110.49 | General |
| Category: Rare Disease | ||||||
| 10/24/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Neurology | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Immunology | ||||||
| 10/22/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Neurology | ||||||
| 10/17/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $27.56 | General |
| Category: Rare Disease | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 458 | 540 | $121,835 | $50,313 |
| 2022 | 9 | 498 | 566 | $128,935 | $56,105 |
| 2021 | 10 | 781 | 878 | $231,896 | $109,207 |
| 2020 | 9 | 766 | 901 | $238,100 | $98,584 |
Total Patients
2,503
Total Services
2,885
Medicare Billing
$314,209
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 96 | 150 | $37,500 | $10,289 | 27.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 63 | 72 | $12,600 | $7,734 | 61.4% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 25 | 25 | $13,375 | $7,608 | 56.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 101 | 112 | $14,000 | $6,071 | 43.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 77 | $11,550 | $5,656 | 49.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 42 | 42 | $13,860 | $5,261 | 38.0% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 28 | 28 | $11,200 | $4,327 | 38.6% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 19 | 19 | $4,750 | $1,804 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,000 | $1,562 | 52.1% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2022 | 37 | 37 | $19,795 | $11,527 | 58.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 90 | 144 | $36,000 | $10,195 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 70 | 76 | $13,300 | $8,642 | 65.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 81 | 83 | $12,450 | $6,529 | 52.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 122 | $15,250 | $5,944 | 39.0% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 38 | 38 | $12,540 | $4,882 | 38.9% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2022 | 26 | 26 | $10,400 | $4,176 | 40.2% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 24 | 24 | $6,000 | $2,453 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $3,200 | $1,756 | 54.9% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Office | 2021 | 113 | 114 | $60,990 | $36,486 | 59.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 76 | 89 | $22,295 | $11,438 | 51.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 172 | 192 | $22,960 | $10,853 | 47.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 86 | 140 | $25,100 | $10,433 | 41.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 86 | 86 | $31,800 | $10,393 | 32.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 114 | 122 | $22,925 | $9,997 | 43.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 50 | 50 | $22,325 | $7,792 | 34.9% |
About Dr. Michael Alt, DO
Dr. Michael Alt, DO is a Neurology healthcare provider based in Louisville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740227255.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Alt, DO has received a total of $15,904 in payments from pharmaceutical and medical device companies, with $2,377 received in 2024. These payments were reported across 986 transactions from 54 companies. The most common payment nature is "Food and Beverage" ($15,426).
As a Medicare-enrolled provider, Alt has provided services to 2,503 Medicare beneficiaries, totaling 2,885 services with total Medicare billing of $314,209. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Louisville, KY
- Active Since 06/01/2006
- Last Updated 04/17/2014
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1740227255
Products in Payments
- APTIOM (Drug) $1,516
- Briviact (Drug) $844.91
- Aimovig (Biological) $636.15
- TYSABRI (Biological) $593.02
- UBRELVY (Drug) $542.41
- KESIMPTA (Drug) $531.11
- NUPLAZID (Drug) $526.42
- AUBAGIO (Drug) $483.92
- VUMERITY (Drug) $470.05
- TECFIDERA (Drug) $395.23
- ULTOMIRIS (Biological) $376.28
- VYVGART (Drug) $320.29
- Fycompa (Drug) $314.91
- Nayzilam (Drug) $310.96
- RYTARY (Drug) $308.30
- OCREVUS (Biological) $296.02
- AIMOVIG (Biological) $288.76
- INBRIJA (Drug) $266.53
- NUEDEXTA (Drug) $241.60
- NURTEC ODT (Drug) $238.16
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Louisville
Adolfo Ramirez-Zamora, M.d, M.D
Neurology — Payments: $360,493
Neurology $360,493
Dr. Kristi Nord, M.d, M.D
Neurology — Payments: $342,417
Neurology $342,417
Dr. Brian Plato, D.o, D.O
Neurology — Payments: $309,983
Neurology $309,983
Dr. Angela Hardwick, M.d, M.D
Neurology — Payments: $259,489
Neurology $259,489
Jeffrey Frank, Md, MD
Neurology — Payments: $232,884
Neurology $232,884
Vinay Puri, M.d, M.D
Neurology — Payments: $225,192
Neurology $225,192